Abbott Laboratories
ABTAbbott Laboratories (ABT) is a Healthcare company that currently yields 2.17% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $80.30 and the overvaluation threshold at $134.62. Abbott Laboratories holds a quality score of 67/100 (Good), reflecting 54 consecutive years of dividend growth with a 67% payout ratio. The 5-year dividend CAGR stands at 12.7%.
ABT Dividend Yield History — Weiss Valuation
Distance to undervalued
Waiting for a better entry
Needs about 14.7% downside to reach the Weiss buy zone
Undervaluation starts near $80.30, where the annual dividend would imply roughly 2.54% yield. That is 0.37% above today's yield.
Buy-zone price
$80.30
Target yield
2.54%
Research checklist
What to clear before buying the yield
Updated Jun 29, 2026
Dividend durability
54YLong dividend history supports a deeper look.
Earnings payout
67%Earnings coverage leaves room for noise.
Cash payout
69%Free cash flow coverage supports the payment.
Dividend growth
12.7%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-06-28 → 2026-06-29
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Abbott Laboratories is trading at a fair valuation relative to its dividend history.
Current yield 2.2% vs historical max 3.5% (63% of maximum).
10 consecutive years without a dividend cut.
Reasonable payout ratio of 67%.
What matters now
Read the signal before the headline yield
Valuation is neutral here: quality has to do more of the work than entry price.
The 67/100 quality score calls for selective follow-up, not autopilot.
Start by checking whether payout coverage and business durability still support the dividend.
ABT Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$244
Year 10 Income
$1,031
Yield on Cost
11.05%
Total Income
$5,417
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what ABT dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗ABT Dividend Quality Score
Quality Score
Good
Key Metrics
Invest in ABT
Buy Abbott Laboratories commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ ABT Dividend Analysis ArticleRelated Reading
Collections